# Question 40

**Type:** Genomic Alteration Frequencies

**Question:** What are the most frequently altered genes in KRAS wild-type lung adenocarcinoma patients?

**Answer:**

I'll help you find the most frequently altered genes in KRAS wild-type lung adenocarcinoma patients. Let me break this down into steps:

1. First, I'll identify lung adenocarcinoma patients
2. Filter for those who are KRAS wild-type (no KRAS mutations)
3. Find the most frequently altered genes in this subset

Let me start by querying the data:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- First, identify KRAS wild-type lung adenocarcinoma samples\nWITH kras_mutant_samples AS (\n    SELECT DISTINCT sample_unique_id\n    FROM genomic_event_derived\n    WHERE cancer_study_identifier = 'msk_chord_2024'\n      AND hugo_gene_symbol = 'KRAS'\n      AND variant_type = 'mutation'\n),\nlung_adeno_samples AS (\n    SELECT DISTINCT sample_unique_id\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'msk_chord_2024'\n      AND attribute_name = 'CANCER_TYPE_DETAILED'\n      AND attribute_value LIKE '%Lung Adenocarcinoma%'\n),\nkras_wt_lung_adeno AS (\n    SELECT sample_unique_id\n    FROM lung_adeno_samples\n    WHERE sample_unique_id NOT IN (SELECT sample_unique_id FROM kras_mutant_samples)\n)\n-- Now find most frequently altered genes in KRAS WT lung adenocarcinoma\nSELECT \n    hugo_gene_symbol,\n    COUNT(DISTINCT sample_unique_id) as num_samples_altered,\n    (SELECT COUNT(DISTINCT sample_unique_id) FROM kras_wt_lung_adeno) as total_samples,\n    ROUND(COUNT(DISTINCT sample_unique_id) * 100.0 / (SELECT COUNT(DISTINCT sample_unique_id) FROM kras_wt_lung_adeno), 2) as percentage_altered\nFROM genomic_event_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND variant_type = 'mutation'\n  AND sample_unique_id IN (SELECT sample_unique_id FROM kras_wt_lung_adeno)\nGROUP BY hugo_gene_symbol\nHAVING num_samples_altered >= 5\nORDER BY num_samples_altered DESC\nLIMIT 20\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"hugo_gene_symbol":"TP53","num_samples_altered":2045,"total_samples":4038,"percentage_altered":50.64},{"hugo_gene_symbol":"EGFR","num_samples_altered":1725,"total_samples":4038,"percentage_altered":42.72},{"hugo_gene_symbol":"KEAP1","num_samples_altered":399,"total_samples":4038,"percentage_altered":9.88},{"hugo_gene_symbol":"STK11","num_samples_altered":379,"total_samples":4038,"percentage_altered":9.39},{"hugo_gene_symbol":"RBM10","num_samples_altered":369,"total_samples":4038,"percentage_altered":9.14},{"hugo_gene_symbol":"NF1","num_samples_altered":306,"total_samples":4038,"percentage_altered":7.58},{"hugo_gene_symbol":"BRAF","num_samples_altered":280,"total_samples":4038,"percentage_altered":6.93},{"hugo_gene_symbol":"PTPRD","num_samples_altered":268,"total_samples":4038,"percentage_altered":6.64},{"hugo_gene_symbol":"SMARCA4","num_samples_altered":258,"total_samples":4038,"percentage_altered":6.39},{"hugo_gene_symbol":"PTPRT","num_samples_altered":251,"total_samples":4038,"percentage_altered":6.22},{"hugo_gene_symbol":"MET","num_samples_altered":244,"total_samples":4038,"percentage_altered":6.04},{"hugo_gene_symbol":"FAT1","num_samples_altered":236,"total_samples":4038,"percentage_altered":5.84},{"hugo_gene_symbol":"ERBB2","num_samples_altered":216,"total_samples":4038,"percentage_altered":5.35},{"hugo_gene_symbol":"SETD2","num_samples_altered":216,"total_samples":4038,"percentage_altered":5.35},{"hugo_gene_symbol":"ARID1A","num_samples_altered":211,"total_samples":4038,"percentage_altered":5.23},{"hugo_gene_symbol":"KMT2D","num_samples_altered":205,"total_samples":4038,"percentage_altered":5.08},{"hugo_gene_symbol":"PIK3CA","num_samples_altered":198,"total_samples":4038,"percentage_altered":4.9},{"hugo_gene_symbol":"KMT2C","num_samples_altered":197,"total_samples":4038,"percentage_altered":4.88},{"hugo_gene_symbol":"RB1","num_samples_altered":196,"total_samples":4038,"percentage_altered":4.85},{"hugo_gene_symbol":"EPHA3","num_samples_altered":189,"total_samples":4038,"percentage_altered":4.68}]}
```


Excellent! Here are the **most frequently altered genes in KRAS wild-type lung adenocarcinoma patients** from the MSK-CHORD 2024 study:

## Top 20 Most Frequently Altered Genes (KRAS WT Lung Adenocarcinoma)

Out of **4,038 KRAS wild-type lung adenocarcinoma samples**:

| Rank | Gene | Samples Altered | Frequency |
|------|------|----------------|-----------|
| 1 | **TP53** | 2,045 | 50.6% |
| 2 | **EGFR** | 1,725 | 42.7% |
| 3 | **KEAP1** | 399 | 9.9% |
| 4 | **STK11** | 379 | 9.4% |
| 5 | **RBM10** | 369 | 9.1% |
| 6 | **NF1** | 306 | 7.6% |
| 7 | **BRAF** | 280 | 6.9% |
| 8 | **PTPRD** | 268 | 6.6% |
| 9 | **SMARCA4** | 258 | 6.4% |
| 10 | **PTPRT** | 251 | 6.2% |
| 11 | **MET** | 244 | 6.0% |
| 12 | **FAT1** | 236 | 5.8% |
| 13 | **ERBB2** | 216 | 5.4% |
| 14 | **SETD2** | 216 | 5.4% |
| 15 | **ARID1A** | 211 | 5.2% |
| 16 | **KMT2D** | 205 | 5.1% |
| 17 | **PIK3CA** | 198 | 4.9% |
| 18 | **KMT2C** | 197 | 4.9% |
| 19 | **RB1** | 196 | 4.9% |
| 20 | **EPHA3** | 189 | 4.7% |

## Key Findings:

- **TP53** is the most frequently altered gene (50.6%), consistent with its role as a common tumor suppressor
- **EGFR** is altered in 42.7% of KRAS WT cases, which is expected as EGFR and KRAS mutations are often mutually exclusive in lung adenocarcinoma
- Other notable alterations include tumor suppressors (**KEAP1**, **STK11**, **NF1**) and chromatin remodeling genes (**SMARCA4**, **ARID1A**, **KMT2D**, **KMT2C**)
- Actionable alterations like **BRAF** (6.9%), **MET** (6.0%), and **ERBB2** (5.4%) are also present

This profile is characteristic of KRAS wild-type lung adenocarcinoma, where EGFR mutations are much more common compared to KRAS-mutant cases.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 16.32502058893442
- **agent_type**: mcp-clickhouse

### Usage
- **input_tokens**: 7945
- **output_tokens**: 1424
- **total_tokens**: 9369
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 13:06:18*